federal_register: 2017-01546

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2017-01546 Program-Specific Guidance About Commercial Radiopharmacy Licenses Notice The U.S. Nuclear Regulatory Commission (NRC) is revising its licensing guidance for licenses authorizing commercial nuclear pharmacy use of byproduct material. The NRC is requesting public comment on draft NUREG-1556, Volume 13, Revision 2, "Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Commercial Radiopharmacy Licenses." The document has been updated from the previous revision to include information on safety culture, security of radioactive materials, protection of sensitive information, and changes in regulatory policies and practices. This document is intended for use by applicants, licensees, and the NRC staff. 2017-01-24 2017 1 https://www.federalregister.gov/documents/2017/01/24/2017-01546/program-specific-guidance-about-commercial-radiopharmacy-licenses https://www.govinfo.gov/content/pkg/FR-2017-01-24/pdf/2017-01546.pdf Nuclear Regulatory Commission 383 The U.S. Nuclear Regulatory Commission (NRC) is revising its licensing guidance for licenses authorizing commercial nuclear pharmacy use of byproduct material. The NRC is requesting public comment on draft NUREG-1556, Volume 13, Revision 2,...  

Links from other tables